CXV.V - Convalo Health International Corp.

TSXV - TSXV Delayed Price. Currency in CAD
0.07
0.00 (0.00%)
At close: 3:46PM EDT
Stock chart is not supported by your current browser
Previous Close0.07
Open0.08
Bid0.06 x 0
Ask0.07 x 0
Day's Range0.07 - 0.08
52 Week Range0.05 - 0.19
Volume329,056
Avg. Volume535,257
Market Cap16.283M
Beta0.25
PE Ratio (TTM)N/A
EPS (TTM)-0.09
Earnings DateJan 29, 2018 - Feb 2, 2018
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est0.68
  • GlobeNewswire9 days ago

    BLVD Centers Provides Update

    BLVD Centers Corporation (“BLVD” or the “Company”) (CXV.V), today announced an operational update as it further organizes for the next period of growth. As was previously announced on May 7, 2018, the Company is looking at opportunities to potentially enter the marijuana industry. Of course, if there is a bid to acquire BLVD, the acquisition would be subject to shareholder approval.

  • GlobeNewswirelast month

    BLVD Centers Announces Plan to List on the Canadian Securities Exchange as Part of its Plan to Move into the US Marijuana Market

    BLVD Centers Corporation (the “Company”) announced today that it has submitted an application to the Canadian Securities Exchange (the “CSE”) to list its common shares on the CSE. Once approved, the Company plans to apply for a voluntary delisting of its common shares from the TSX Venture Exchange (“TSXV”), subject to necessary regulatory approvals. The Company's move from the TSXV to the CSE follows several announcements since the start of 2018 highlighting plans to expand its product and services offering into the US cannabis market, possibly through direct sales of marijuana.

  • GlobeNewswire2 months ago

    BLVD Centers Announces Weedaide™ is Available for Preorder in Advance of Product Launch

    NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. LOS ANGELES, April 10, 2018-- BLVD Centers Corporation, a leading company in the United States addiction ...

  • ACCESSWIRE3 months ago

    Today’s Research Reports on Annidis, Antibe Therapeutics, BLVD Centers and Cotinga Pharmaceuticals

    NEW YORK, NY / ACCESSWIRE / March 26, 2018 / Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register ...

  • Marketwired6 months ago

    BLVD Centers Unaware of Any Material Change

    NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES BLVD Centers Corporation , a leading company in the United States addiction recovery industry, announces ...

  • CNW Group6 months ago

    IIROC Trading Halt - CXV

    VANCOUVER , Jan. 3, 2018 /CNW/ - The following issues have been halted by IIROC: Company: BLVD Centers Corporation TSX-Venture Symbol: CXV Reason: Pending Company Contact Halt Time (ET): 10:29 IIROC can ...

  • PR Newswire6 months ago

    IIROC Trading Halt - CXV

    VANCOUVER , Jan. 3, 2018 /CNW/ - The following issues have been halted by IIROC: Company: BLVD Centers Corporation TSX-Venture Symbol: CXV Reason: Pending Company Contact Halt Time (ET): 10:29 IIROC can ...